Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05083403 · ClinicalTrials.gov registry record · NA
HPI (Hypotension Prediction Index) Care Trial
A NA study of Cardiopulmonary Bypass Surgery, sponsored by Edwards Lifesciences.
- Active
- Registry status
- NA
- Development phase
- 350
- Enrollment target
- 1
- Study location
NCT05083403 is a NA study of Cardiopulmonary Bypass Surgery that is active but no longer recruiting, run by Edwards Lifesciences. The registered enrollment target is 350 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05083403, a NA study of Cardiopulmonary Bypass Surgery, is active but no longer recruiting, sponsored by Edwards Lifesciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective single-center randomized controlled trial to determine if guided hemodynamic management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of hypotension in cardiac surgery patients requiring cardiopulmonary bypass.
Conditions Studied
Interventions
- DEVICE AcumenTM HPI Software Feature
- OTHER Non-protocolized Standard of Care
Study Locations (1)
North Carolina
- Wake Forest Baptist Medical Center - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2022-03-28 |
| Est. Completion | 2025-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05083403
The ClinicalTrials.gov registry entry for NCT05083403 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Edwards Lifesciences, which has 57 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiopulmonary Bypass Surgery appearing as the primary indexed condition, and to 2 interventions - of which AcumenTM HPI Software Feature is the first listed.
NCT05083403 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT05083403 about?
NCT05083403 is a clinical study titled "HPI (Hypotension Prediction Index) Care Trial". A prospective single-center randomized controlled trial to determine if guided hemodynamic management with the Acumen HPI technology in the OR and ICU can reduce the mean duration of hypotension in cardiac surgery patients requiring cardiopulmonary bypass.
What is the current status of trial NCT05083403?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2022-03-28. Estimated completion is 2025-11.
What conditions does trial NCT05083403 study?
This clinical trial studies the following conditions: Cardiopulmonary Bypass Surgery.
What interventions are being tested in trial NCT05083403?
The interventions under investigation include: AcumenTM HPI Software Feature (DEVICE), Non-protocolized Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05083403?
This trial is sponsored by Edwards Lifesciences, which has 57 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05083403 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.